-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pancreatic ductal adenocarcinoma (PDAC) is an insidious onset and a malignancy with a poor prognosis, with a five-year survival rate of less than 7%, and is characterized by prominent genomic aberrations and increased glycolytic phenotypes
Recently, a joint research team from the Sutton Cancer Institute in the United Kingdom and Imperial College London discovered a protein (GREM1) that plays a key role in the growth and metastasis of pancreatic cancer
Paper link:
#additional-information